99mTc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following 90Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD)

20260 citationsJournal Articlediamond Open Access

Authors

Ali Bassir · SUNY Upstate Medical University

Casey Dang · SUNY Upstate Medical University

Kenneth Chiu · SUNY Upstate Medical University

Sravani Gampala · SUNY Upstate Medical University

Taylor Loon · SUNY Upstate Medical University

Abhijit Salaskar · SUNY Upstate Medical University

Katsuhiro Kobayashi

Abstract

99mTc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following 90Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD)

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Medical Imaging and Pathology Studies Management of metastatic bone disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Quantitative Imaging in Medicine and Surgery

Volume 16, Issue 4, pp. 307-307

DOI: 10.21037/qims-2025-1242

Field-Weighted Citation Impact: 0.00

Command Palette

99mTc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following 90Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD)

Authors

Abstract

Topics & Keywords

UN Sustainable Development Goals

Publication Details